Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA)

49 filings reported holding CNTA - Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share as of Q2 2021.
Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 47,409,892 shares of 147,336,360 outstanding shares and own 32.18% of the company stock.
Largest 10 shareholders include Medicxi Ventures Management (Jersey) Ltd (17,923,892 shares), JANUS HENDERSON GROUP PLC (5,680,933 shares), Vida Ventures Advisors, LLC (3,931,818 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,011,073 shares), Samsara BioCapital, LLC (1,537,533 shares), GENERAL ATLANTIC, L.P. (1,500,000 shares), Cormorant Asset Management, LP (1,427,273 shares), RA CAPITAL MANAGEMENT, L.P. (1,280,300 shares), VR Adviser, LLC (1,127,272 shares), and WELLINGTON MANAGEMENT GROUP LLP (1,106,577 shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.